Gene · 8321
Papers2,162
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,162
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Wnt Signaling and Therapeutic Resistance in Castration-Resistant Prostate Cancer. | Curr Pharmacol Rep | 2023 | 37994344 | PubTator, text mining | PubMed |
| Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect. | J Transl Med | 2023 | 37932756 | PubTator, text mining | PubMed |
| FTO-mediated LINC01134 stabilization to promote chemoresistance through miR-140-3p/WNT5A/WNT pathway in PDAC. | Cell Death Dis | 2023 | 37914721 | PubTator, text mining | PubMed |
| Beta-1,4-galactosyltransferase-3 deficiency suppresses the growth of immunogenic tumors in mice. | Front Immunol | 2023 | 37901252 | PubTator, text mining | PubMed |
| Molecular Insight into Prostate Cancer: Preventive Role of Selective Bioactive Molecules. | Life (Basel) | 2023 | 37895357 | PubTator, text mining | PubMed |
| Regulation of self-renewal and senescence in primitive mesenchymal stem cells by Wnt and TGFβ signaling. | Stem Cell Res Ther | 2023 | 37880755 | PubTator, text mining | PubMed |
| Addition of exogenous diacylglycerol enhances Wnt/β-catenin signaling through stimulation of macropinocytosis. | iScience | 2023 | 37860772 | PubTator, text mining | PubMed |
| Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer. | Front Pharmacol | 2023 | 37841927 | PubTator, text mining | PubMed |
| Rho-Kinase Inhibitors as Emerging Targets for Glaucoma Therapy. | Ophthalmol Ther | 2023 | 37837578 | PubTator, text mining | PubMed |
| Sclerostin, Osteocytes, and Wnt Signaling in Pediatric Renal Osteodystrophy. | Nutrients | 2023 | 37836411 | PubTator, text mining | PubMed |
| Identification of molecular pattern and prognostic risk model based on ligand-receptor pairs in liver cancer. | Front Immunol | 2023 | 37818360 | PubTator, text mining | PubMed |
| Expression pattern, prognostic value and potential microRNA silencing of FZD8 in breast cancer. | Oncol Lett | 2023 | 37809047 | PubTator, text mining | PubMed |
| Adult tissue-specific stem cell interaction: novel technologies and research advances. | Front Cell Dev Biol | 2023 | 37808078 | PubTator, text mining | PubMed |
| FZD7: A potential biomarker for endometriosis. | Medicine (Baltimore) | 2023 | 37800830 | PubTator, text mining | PubMed |
| APPlications of amyloid-β precursor protein metabolites in macrocephaly and autism spectrum disorder. | Front Mol Neurosci | 2023 | 37799731 | PubTator, text mining | PubMed |
| GPC3 gene expression and allelic discrimination of FZD7 gene in Egyptian patients with hepatocellular carcinoma. | Rep Pract Oncol Radiother | 2023 | 37795234 | PubTator, text mining | PubMed |
| Role of non-canonical post-translational modifications in gastrointestinal tumors. | Cancer Cell Int | 2023 | 37777749 | PubTator, text mining | PubMed |
| HCMV UL8 interaction with β-catenin and DVL2 regulates viral reactivation in CD34+ hematopoietic progenitor cells. | J Virol | 2023 | 37772824 | PubTator, text mining | PubMed |
| WNT pathway in focal cortical dysplasia compared to perilesional nonlesional tissue in refractory epilepsies. | BMC Neurol | 2023 | 37749503 | PubTator, text mining | PubMed |
| Potential molecular targets for intervention in pelvic organ prolapse. | Front Med (Lausanne) | 2023 | 37731721 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8321/papers?page=6